AnGes OTC Stock Top Insiders
| AMGXF Stock | USD 0.36 0.00 0.00% |
AnGes employs about 131 people. The company is managed by 2 executives with a total tenure of roughly 306 years, averaging almost 153.0 years of service per executive, having 65.5 employees per reported executive. Examination of AnGes' management performance can provide insight into the company performance.
| Naoya Sato Insider Director Director |
| Ei MD Insider Pres CEO |
AnGes |
AnGes Management Team Effectiveness
The company has return on total asset (ROA) of (0.242) % which means that it has lost $0.242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4262) %, meaning that it generated substantial loss on money invested by shareholders. AnGes' management efficiency ratios could be used to measure how well AnGes manages its routine affairs as well as how well it operates its assets and liabilities.AnGes Workforce Comparison
AnGes Inc is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 2,986. AnGes holds roughly 131 in number of employees claiming about 4% of stocks in Biotechnology industry.
AnGes Inc Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. AnGes Inc Price Series Summation is a cross summation of AnGes price series and its benchmark/peer.
AnGes Notable Stakeholders
An AnGes stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AnGes often face trade-offs trying to please all of them. AnGes' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AnGes' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Naoya Sato | Director Director | Profile | |
| Ei MD | Pres CEO | Profile |
About AnGes Management Performance
The success or failure of an entity such as AnGes Inc often depends on how effective the management is. AnGes management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AnGes management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AnGes management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.
The data published in AnGes' official financial statements typically reflect AnGes' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving AnGes' quantitative information. For example, before you start analyzing numbers published by AnGes accountants, it's essential to understand AnGes' liquidity, profitability, and earnings quality within the context of the Healthcare space in which it operates.
AnGes Workforce Analysis
Traditionally, organizations such as AnGes use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AnGes within its industry.AnGes Manpower Efficiency
Return on AnGes Manpower
| Revenue Per Employee | 489.7K | |
| Revenue Per Executive | 32.1M | |
| Net Loss Per Employee | 104.4M | |
| Net Loss Per Executive | 6.8B |
Complementary Tools for AnGes OTC Stock analysis
When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |